ImmunityBio Inc (IBRX)
3.055
+0.18
(+6.45%)
USD |
NASDAQ |
Dec 16, 16:00
3.08
+0.02
(+0.82%)
After-Hours: 20:00
ImmunityBio Shareholders Equity (Quarterly): -745.15M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Q32 Bio Inc | 18.30M |
| HCA Healthcare Inc | -2.182B |
| Biomarin Pharmaceutical Inc | 5.413B |
| Incyte Corp | 3.171B |
| Insmed Inc | 483.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 364.57M |
| Total Liabilities (Quarterly) | 1.109B |
| Debt to Equity Ratio | -0.9382 |
| Current Ratio | 2.676 |
| Net Debt Paydown Yield | 0.54% |